Cargando…
Equity in HTA: what doesn’t get measured, gets marginalised
When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. Less atten...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502411/ https://www.ncbi.nlm.nih.gov/pubmed/28694961 http://dx.doi.org/10.1186/s13584-017-0162-3 |